31 filings
10-Q
2024 Q1
KYTX
Kyverna Therapeutics Inc.
14 May 24
Quarterly report
4:29pm
8-K
KYTX
Kyverna Therapeutics Inc.
14 May 24
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
4:25pm
10-K
2023 FY
KYTX
Kyverna Therapeutics Inc.
26 Mar 24
Annual report
4:40pm
8-K
KYTX
Kyverna Therapeutics Inc.
26 Mar 24
Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results
4:13pm
SEC STAFF
KYTX
Kyverna Therapeutics Inc.
13 Feb 24
SEC staff action: Order
12:00am
8-K
sdxptqmgjacgr
12 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:34pm
S-8
evgdzc3eviz 043xie
8 Feb 24
Registration of securities for employees
4:44pm
424B4
rqt8no
8 Feb 24
Prospectus supplement with pricing info
4:05pm
CERT
46z3ui2c1 p8
8 Feb 24
Certification of approval for exchange listing
8:15am
EFFECT
bq5611
8 Feb 24
Notice of effectiveness
12:15am
8-A12B
7o0qkn
5 Feb 24
Registration of securities on exchange
4:01pm
CORRESP
q690dy9ihqhbmrtq28zs
5 Feb 24
Correspondence with SEC
12:00am
CORRESP
o7ed 3h5sc97v
5 Feb 24
Correspondence with SEC
12:00am
S-1/A
qs8b 9qbnrotvltc81
31 Jan 24
IPO registration (amended)
9:47pm
CORRESP
asq7484rhskmc0rmj0xt
25 Jan 24
Correspondence with SEC
12:00am
S-1
cyt6vx
16 Jan 24
IPO registration
4:46pm
CORRESP
x4f5 29mk3etkom
16 Jan 24
Correspondence with SEC
12:00am
UPLOAD
3ia40x03v3a h15uqg
10 Jan 24
Letter from SEC
12:00am
DRS/A
vei29i8y3m nrnt5
8 Jan 24
Draft registration statement (amended)
12:00am